Related Experiment Video

Updated: Aug 12, 2026

Mimicking the Function of Signaling Proteins: Toward Artificial Signal Transduction Therapy
12:24

Mimicking the Function of Signaling Proteins: Toward Artificial Signal Transduction Therapy

Published on: September 29, 2016

IBC's 4th Annual Conference on Signal Transduction Therapy: novel targets for therapeutic intervention

S A Goueli1

  • 1Promega Corporation, 2800 Woods Hollow Road, Madison, WI 53711-5399, USA. sgoueli@promega.com

Expert Opinion on Investigational Drugs
|July 5, 2005
PubMed

Insights

Researchers explored cell signaling pathways for novel drug targets. Key areas included protein kinase A, Ras, growth factor receptors, and cytokine signaling, aiming for new therapeutic strategies.

Area of Science:

  • Molecular Biology
  • Pharmacology
  • Cellular Biology

Background:

  • Cell signaling pathways regulate numerous cellular processes.
  • Dysregulation of these pathways is implicated in various diseases.
  • Targeting specific signaling molecules offers therapeutic potential.

Purpose of the Study:

  • To present diverse strategies for investigating cell signaling.
  • To identify and validate novel drug targets within signaling pathways.
  • To explore the rationale behind targeting specific signaling mechanisms.

Main Methods:

  • Review of various research approaches in cell signaling.
  • Discussion of specific targets such as protein kinase A anchoring.
  • Analysis of Ras-dependent transformation and growth factor receptor tyrosine kinases.

Main Results:

  • Identification of multiple druggable targets within key signaling pathways.
  • Demonstration of diverse methodologies for pathway investigation.
  • Highlighting the therapeutic potential of targeting cytokine signaling and immunosuppressant enzymes.

Conclusions:

  • Cell signaling pathways represent a rich source of drug targets.
  • Targeting specific components like protein kinase A and Ras can yield therapeutic benefits.
  • Further investigation into cytokine-mediated signaling and enzyme targets is warranted for drug development.

More Related Videos

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays07:42

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays

Published on: September 19, 2018

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization03:08

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization

Published on: October 3, 2025

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...